List of Sentri7 Drug Diversion Customers
Alphen aan den Rijn, 2400 BA,
Netherlands
Since 2010, our global team of researchers has been studying Sentri7 Drug Diversion customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Sentri7 Drug Diversion for Pharmacy Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Sentri7 Drug Diversion for Pharmacy Management include: Piedmont Augusta, a United States based Healthcare organisation with 31000 employees and revenues of $6.00 billion, Aultman Health, a United States based Insurance organisation with 7000 employees and revenues of $2.00 billion, Piedmont Athens Regional, a United States based Healthcare organisation with 3300 employees and revenues of $460.0 million, Mary Lanning Healthcare, a United States based Healthcare organisation with 500 employees and revenues of $65.0 million and many others.
Contact us if you need a completed and verified list of companies using Sentri7 Drug Diversion, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Sentri7 Drug Diversion customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Aultman Health | Insurance | 7000 | $2.0B | United States | Wolters Kluwer | Sentri7 Drug Diversion | Pharmacy Management | 2015 | n/a |
In 2015, Aultman Health implemented Wolters Kluwer’s Sentri7 Pharmacy surveillance within its Pharmacy Management environment, and adoption of the Sentri7 Drug Diversion module is inferred from the hospital’s broader Sentri7 suite deployment. The narrative links the deployment to Aultman Hospital in Canton, Ohio, and places Sentri7 Drug Diversion in the context of the hospital’s pharmacy surveillance and antimicrobial stewardship program.
The implementation documented use of Sentri7 Pharmacy and antimicrobial stewardship capabilities to surface antimicrobial use patterns and to generate stewardship intervention workflows for the hospital pharmacy and the antimicrobial stewardship team. Based on the documented Sentri7 footprint, inferred Sentri7 Drug Diversion functionality would align with controlled substance monitoring, automated alerting for diversion indicators, and case workflow orchestration within Pharmacy Management.
Governance and clinical workflow alignment are evidenced by a reported approximately 95% physician acceptance rate for stewardship interventions, and the case study attributes roughly $2 million in savings to the Sentri7 Pharmacy/AMS deployment. The source documents outcomes for Sentri7 Pharmacy and antimicrobial stewardship explicitly, while attribution of those outcomes specifically to Sentri7 Drug Diversion is inferred rather than stated.
|
 |
Mary Lanning Healthcare | Healthcare | 500 | $65M | United States | Wolters Kluwer | Sentri7 Drug Diversion | Pharmacy Management | 2023 | n/a |
In 2023, Mary Lanning Healthcare implemented Sentri7 Drug Diversion, deploying a Pharmacy Management solution across its U.S. community health system in Hastings, Nebraska. The Sentri7 Drug Diversion deployment is scoped to enable proactive drug diversion surveillance and to formalize diversion investigation workflows used by pharmacy operations and clinical staff. Configuration emphasized surveillance rules, alerting, and case management capabilities consistent with Pharmacy Management functional workflows, tuned to surface anomalous medication movement for investigator review.
The implementation aligns with Wolters Kluwer’s integration of Invistics/Flowlytics into the Sentri7 suite, bringing enhanced analytics and automated pattern detection into Sentri7 Drug Diversion. Operational coverage targets inpatient and outpatient pharmacy processes and connects into compliance and risk governance practices to standardize investigation intake, evidence collection, and escalation workflows. Public statements from Mary Lanning Healthcare cite an improved ability to be proactive in diversion surveillance and to align internal investigation processes with the Sentri7 Drug Diversion toolset.
|
 |
Piedmont Athens Regional | Healthcare | 3300 | $460M | United States | Wolters Kluwer | Sentri7 Drug Diversion | Pharmacy Management | 2025 | n/a |
In 2025 Piedmont Athens Regional implemented Sentri7 Drug Diversion as part of its Pharmacy Management tooling to detect, investigate, and prevent drug diversion across clinical departments. The deployment consolidated 33 months of historical records covering over 4.6 million drug transactions executed by 1,850 healthcare professionals, establishing baseline analytics and enabling real time monitoring with the Sentri7 Drug Diversion application.
The implementation featured advanced analytics and machine learning modules that classified transactions and generated actionable alerts, supported by intuitive dashboards and heat map reporting. Functional capabilities included anomaly detection against historical baselines, real time alerting for suspicious transactional patterns, and investigative dashboards that surfaced both known diversion cases and newly suspected behaviors.
Architecturally the solution ingested and unified data from five distinct hospital IT systems, including Automated Dispensing Machines ADM, Electronic Medical Records EMR, wholesaler purchasing systems, internal inventory systems, and employee time clocks into a single analytic datastore. Data integration enabled cross system transaction linkage across Nursing, Anesthesia, and Pharmacy workflows, allowing multidisciplinary visibility into drug movement and user activity.
Governance and process changes emphasized collaborative reporting and cross functional investigation, with pharmacy, nursing, and compliance stakeholders using dashboards and heat maps to differentiate poor practice from diversion and to coordinate follow up. Outcomes documented in the Piedmont Athens case study include detection of nine pre identified diversion cases flagged by machine learning ahead of traditional timelines, identification of additional suspected cases under investigation, and accelerated investigative workflows through integrated, historically informed insights.
|
 |
|
Healthcare | 31000 | $6.0B | United States | Wolters Kluwer | Sentri7 Drug Diversion | Pharmacy Management | 2017 | n/a |
|
Buyer Intent: Companies Evaluating Sentri7 Drug Diversion
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||